| 标题 |
Targeting EZH2 and EGFR Therapeutic Vulnerabilities of TNBC with a Single Chemical Entity Confers Preclinical Treatment Advantage |
| 网址 | |
| DOI | |
| 其它 |
期刊:Molecular Therapy 作者:Saumya Ranjan Satrusal; Arpita Banerjee; Arpon Biswas; Gaurava Srivastava; Indranil Chatterjee; et al 出版日期:2026-08-25 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)